Insulin-like growth factor 1 predicts post-load hypoglycemia following bariatric surgery: A prospective cohort study

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Itariu, Bianca K ^a   Zeyda, Maximilian ^a   Prager, Gerhard ^a   Stulnig, Thomas M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; GLUCOSE; INSULIN; SOMATOMEDIN C;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; MALE; ORAL GLUCOSE TOLERANCE TEST; POST LOAD HYPOGLYCEMIA; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECURRENCE RISK; RISK ASSESSMENT; STOMACH BYPASS; BLOOD; GLUCOSE TOLERANCE TEST; LONGITUDINAL STUDY; METABOLISM; RISK;

ADULT; BARIATRIC SURGERY; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIA; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; RISK;

EID: 84899680697     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094613     Document Type: Article

References (47)

1. Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M (2007) Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. International journal of obesity 31: 1248-1261. (Pubitemid 47172616)
2. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, et al. (2007) Longterm mortality after gastric bypass surgery. The New England journal of medicine 357: 753-761. (Pubitemid 47295642)
3. Neff KJ, Olbers T, le Roux CW (2013) Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes. BMC medicine 11: 8.
4. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, et al. (2005) Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. The New England journal of medicine 353: 249-254. (Pubitemid 41058324)
5. Kim SH, Liu TC, Abbasi F, Lamendola C, Morton JM, et al. (2009) Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopenia. Obesity surgery 19: 1550-1556.
6. Parsaik AK, Carter RE, Myers LA, Dong M, Basu A, et al. (2012) Outcomes of community-dwelling adults without diabetes mellitus who require ambulance services for hypoglycemia. Journal of diabetes science and technology 6: 1107-1113.
7. Marsk R, Jonas E, Rasmussen F, Naslund E (2010) Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia 53: 2307-2311.
8. Roslin M, Damani T, Oren J, Andrews R, Yatco E, et al. (2011) Abnormal glucose tolerance testing following gastric bypass demonstrates reactive hypoglycemia. Surgical endoscopy 25: 1926-1932.
9. Patti ME, Goldfine AB (2010) Hypoglycaemia following gastric bypass surgery- - diabetes remission in the extreme? Diabetologia 53: 2276-2279.
10. Clancy TE, Moore FD Jr, Zinner MJ (2006) Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 10: 1116-1119. (Pubitemid 44332983)
11. Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, et al. (2005) Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48: 2236-2240. (Pubitemid 41618912)
12. Anderwald CH, Tura A, Promintzer-Schifferl M, Prager G, Stadler M, et al. (2012) Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery. Diabetes care 35: 2580-2587.
13. Holdstock C, Zethelius B, Sundbom M, Karlsson FA, Eden Engstrom B (2008) Postprandial changes in gut regulatory peptides in gastric bypass patients. International journal of obesity 32: 1640-1646.
14. Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, et al. (2007) Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. The Journal of clinical endocrinology and metabolism 92: 4678-4685. (Pubitemid 350223444)
15. Roth DA, Meade RC (1965) Hyperinsulinism-Hypoglycemia in the Postgastrectomy Patient. Diabetes 14: 526-528.
16. Moreira RO, Moreira RB, Machado NA, Goncalves TB, Coutinho WF (2008) Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obesity surgery 18: 1618-1621.
17. Cui Y, Elahi D, Andersen DK (2011) Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 15: 1879-1888.
18. Clemmons DR (2004) Role of insulin-like growth factor iin maintaining normal glucose homeostasis. Hormone research 62 Suppl 1: 77-82. (Pubitemid 40529154)
19. Zoidis E, Ghirlanda-Keller C, Schmid C (2011) Stimulation of glucose transport in osteoblastic cells by parathyroid hormone and insulin-like growth factor I. Molecular and cellular biochemistry 348: 33-42.
20. Laron Z (2001) Insulin-like growth factor 1 (IGF-1): a growth hormone. Molecular pathology: MP 54: 311-316. (Pubitemid 32928257)
21. Key TJ, Appleby PN, Reeves GK, Roddam AW (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. The lancet oncology 11: 530-542.
22. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, et al. (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Annals of internal medicine 149: 461-471, W483-468.
23. Sesti G, Sciacqua A, Cardellini M, Marini MA, Maio R, et al. (2005) Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes care 28: 120-125. (Pubitemid 40095793)
24. Friedrich N, Thuesen B, Jorgensen T, Juul A, Spielhagen C, et al. (2012) The association between IGF-I and insulin resistance: a general population study in Danish adults. Diabetes care 35: 768-773.
25. Pellitero S, Granada ML, Martinez E, Balibrea JM, Guanyabens E, et al. (2013) IGF1 modifications after bariatric surgery in morbidly obese patients: potential implications of nutritional status according to specific surgical technique. European journal of endocrinology / European Federation of Endocrine Societies 169: 695-703.
26. Mittempergher F, Pata G, Crea N, Di Betta E, Vilardi A, et al. (2013) Preoperative prediction of growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis modification and postoperative changes in candidates for bariatric surgery. Obes Surg 23: 594-601.
27. Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE (2007) Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. The Journal of clinical endocrinology and metabolism 92: 902-910. (Pubitemid 46465661)
28. Rumilla KM, Erickson LA, Service FJ, Vella A, Thompson GB, et al. (2009) Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 22: 239-245.
29. Itariu BK, Zeyda M, Hochbrugger EE, Neuhofer A, Prager G, et al. (2012) Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. The American journal of clinical nutrition 96: 1137-1149.
30. Itariu BK, Zeyda M, Leitner L, Marculescu R, Stulnig TM (2013) Treatment with n-3 polyunsaturated fatty acids overcomes the inverse association of vitamin D deficiency with inflammation in severely obese patients: a randomized controlled trial. PloS one 8: e54634.
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. (Pubitemid 15018832)
32. Anderwald CH, Tura A, Gessl A, Luger A, Pacini G, et al. (2013) Adequately adapted insulin secretion and decreased hepatic insulin extraction cause elevated insulin concentrations in insulin resistant non-diabetic adrenal incidentaloma patients. PloS one 8: e77326.
33. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes care 22: 1462-1470. (Pubitemid 29418240)
34. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic medicine: a journal of the British Diabetic Association 23: 469-480.
35. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, et al. (2006) The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC gastroenterology 6: 33.
36. Rinderknecht E, Humbel RE (1978) The amino acid sequence of human insulinlike growth factor I and its structural homology with proinsulin. The Journal of biological chemistry 253: 2769-2776. (Pubitemid 8326483)
37. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, et al. (2001) Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50: 1110-1118. (Pubitemid 32374542)
38. Ogiwara Y, Mori S, Iwama M, Sawabe M, Takemoto M, et al. (2010) Hypoglycemia due to ectopic secretion of insulin-like growth factor-I in a patient with an isolated sarcoidosis of the spleen. Endocrine journal 57: 325-330.
39. Li JB, Wang CY, Chen JW, Feng ZQ, Ma HT (2004) Expression of liver insulinlike growth factor 1 gene and its serum level in patients with diabetes. World journal of gastroenterology: WJG 10: 255-259.
40. Laron Z (1999) The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome. The Journal of clinical endocrinology and metabolism 84: 4397-4404.
41. Gram IT, Norat T, Rinaldi S, Dossus L, Lukanova A, et al. (2006) Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. International journal of obesity 30: 1623-1631. (Pubitemid 44657836)
42. Hirsch FF, Pareja JC, Geloneze SR, Chaim E, Cazzo E, et al. (2012) Comparison of metabolic effects of surgical-induced massive weight loss in patients with long-term remission versus non-remission of type 2 diabetes. Obes Surg 22: 910-917.
43. Khoo CM, Muehlbauer MJ, Stevens RD, Pamuklar Z, Chen J, et al. (2013) Postprandial Metabolite Profiles Reveal Differential Nutrient Handling After Bariatric Surgery Compared With Matched Caloric Restriction. Annals of surgery.
44. Mitchell JE, Crosby R, de Zwaan M, Engel S, Roerig J, et al. (2013) Possible risk factors for increased suicide following bariatric surgery. Obesity 21: 665-672.
45. Chaput JP, Tremblay A (2009) The glucostatic theory of appetite control and the risk of obesity and diabetes. International journal of obesity 33: 46-53.
46. Cox DJ, Gonder-Frederick LA, Kovatchev BP, Julian DM, Clarke WL (2000) Progressive hypoglycemia's impact on driving simulation performance. Occurrence, awareness and correction. Diabetes care 23: 163-170.
47. Buchwald H, Oien DM (2013) Metabolic/bariatric surgery worldwide 2011. Obesity surgery 23: 427-436.